PMID- 18651730 OWN - NLM STAT- MEDLINE DCOM- 20080908 LR - 20151119 IS - 1520-4804 (Electronic) IS - 0022-2623 (Linking) VI - 51 IP - 15 DP - 2008 Aug 14 TI - Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety. PG - 4804-22 LID - 10.1021/jm800222k [doi] AB - We designed a series of benzoic acid derivatives containing the biphenyl ether or biphenyl template on the RHS and a phenylethanolaminotetraline (PEAT) skeleton, which was prepared by highly stereoselective synthesis, to generate two structurally different lead compounds ( 10c, 10m) with a good balance of potency, selectivity, and pharmacokinetic profile. Further optimization of the two lead compounds to improve potency led to several potential candidates (i.e., 11f, 11l, 11o, 12b). In particular, biphenyl analogue 12b exhibited an excellent balance of high potency (EC50 = 0.38 nM) for beta3, high selectivity over beta1 and beta2, and good pharmacokinetic properties in rats, dogs, and monkeys. FAU - Imanishi, Masashi AU - Imanishi M AD - Chemistry Research Laboratories, Pharmacological Research Laboratories, Applied Pharmacology Research Laboratories, Astellas Pharma Inc, Tsukuba-shi, Ibaraki, Japan. FAU - Nakajima, Yutaka AU - Nakajima Y FAU - Tomishima, Yasuyo AU - Tomishima Y FAU - Hamashima, Hitoshi AU - Hamashima H FAU - Washizuka, Kenichi AU - Washizuka K FAU - Sakurai, Minoru AU - Sakurai M FAU - Matsui, Shigeo AU - Matsui S FAU - Imamura, Emiko AU - Imamura E FAU - Ueshima, Koji AU - Ueshima K FAU - Yamamoto, Takao AU - Yamamoto T FAU - Yamamoto, Nobuhiro AU - Yamamoto N FAU - Ishikawa, Hirofumi AU - Ishikawa H FAU - Nakano, Keiko AU - Nakano K FAU - Unami, Naoko AU - Unami N FAU - Hamada, Kaori AU - Hamada K FAU - Matsumura, Yasuhiro AU - Matsumura Y FAU - Takamura, Fujiko AU - Takamura F FAU - Hattori, Kouji AU - Hattori K LA - eng PT - Journal Article DEP - 20080724 PL - United States TA - J Med Chem JT - Journal of medicinal chemistry JID - 9716531 RN - 0 (Adrenergic Agonists) RN - 0 (Adrenergic beta-3 Receptor Agonists) RN - 0 (Biphenyl Compounds) RN - 0 (Boronic Acids) RN - 0 (Epoxy Compounds) RN - 0 (Receptors, Adrenergic, beta-3) RN - 0 (Tetrahydronaphthalenes) RN - 0F5N573A2Y (Ether) RN - 7568-93-6 (2-Hydroxyphenethylamine) RN - 8SKN0B0MIM (Benzoic Acid) SB - IM MH - 2-Hydroxyphenethylamine/*analogs & derivatives/chemistry MH - Administration, Oral MH - Adrenergic Agonists/*chemical synthesis/chemistry/*pharmacology MH - *Adrenergic beta-3 Receptor Agonists MH - Animals MH - Benzoic Acid/*chemical synthesis/chemistry/*pharmacology MH - Biphenyl Compounds/*chemistry MH - Boronic Acids/chemistry MH - CHO Cells MH - Cricetinae MH - Cricetulus MH - Dogs MH - Epoxy Compounds/administration & dosage/chemistry MH - Ether/chemistry MH - Humans MH - Molecular Structure MH - Receptors, Adrenergic, beta-3/metabolism MH - Structure-Activity Relationship MH - Tetrahydronaphthalenes/*chemistry EDAT- 2008/07/25 09:00 MHDA- 2008/09/09 09:00 CRDT- 2008/07/25 09:00 PHST- 2008/07/25 09:00 [pubmed] PHST- 2008/09/09 09:00 [medline] PHST- 2008/07/25 09:00 [entrez] AID - 10.1021/jm800222k [doi] PST - ppublish SO - J Med Chem. 2008 Aug 14;51(15):4804-22. doi: 10.1021/jm800222k. Epub 2008 Jul 24.